NS-398和抗癌药联用对胃癌细胞增殖的影响(2)
 |
| 第1页 |
参见附件(1431KB，2页)。
[3] Pavlovic S,Du B,Sakamoto K,et al. Targeting prostaglandin E-2 receptors as an alternative stratey to block cyclooxygenase-2-dependent ex- tracellular matrix-induced matrix metalloproteinase-9 expression by macrophages[J]. J Biol Chen,2006,281(6):3321-3328.
[4] Gately S,Kerbel R. Therapeutic potential of selective cyclooxygenase-2 inhibitor in the management of tumor angiogenesis[J]. Prog Exp Tumor Res,2003,37:179-192.
[5] Kaufmann SH,Peereboom D,Buckwalter CA,et al. Cytotoxic effects of lopolecan combined with various anticancer agents in human cancer cell lines[J]. J Natl Cancer Inst,1996,88(11):734-741.
[6] 刘红英,张俐. 尼美舒利增强丝裂霉素抑制体外培养人胃癌细胞的细胞增殖及诱导调亡的实验研究[J]. 中华消化内镜杂志,2004,21(4):734-741.
[7] Guda K,Marino JN,Jung Y,et al. Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice[J]. Int J Oncol,2007,31(4):837-842.
[8] Richie-JP JR,Komninou D,Albino AP,et al. Induction of colon tumorigenesis by glutathione depletion in p53-knock-out mice[J]. Int J Oncol,2007,30(6):1539-1543.
[9] Soslow RA,Dannenberg AJ,Rush D,et al. COX-2 is expressed in human pumomary,colonic,and mammary tumor[J]. Cancer,2000,89(12):2637- 2645.
[10] Meyskens FL Jr,McLaren CE,Pelot D,et al. Difluoromethylornithine plus Sulindac for the prevention of sporadic colorectal adenomas:a randomized placebo controlled,double-blind trial[J]. Cancer Prev,Res,2008, 1(1):32-38.
(收稿日期:2009-11-05)
您现在查看是摘要介绍页，详见PDF附件(1431KB，2页)。